THALLOUS CHLORIDE TI-201 INJECTION SOLUTION

Krajina: Kanada

Jazyk: angličtina

Zdroj: Health Canada

Aktívna zložka:

THALLIUM CHLORIDE(TI 201)

Dostupné z:

CURIUM CANADA INC

ATC kód:

V09GX01

INN (Medzinárodný Name):

THALLIUM 201 TL CHLORIDE

Dávkovanie:

37MBq

Forma lieku:

SOLUTION

Zloženie:

THALLIUM CHLORIDE(TI 201) 37MBq

Spôsob podávania:

INTRAVENOUS

Počet v balení:

10ML

Typ predpisu:

Schedule C

Terapeutické oblasti:

ROENTGENOGRAPHY

Prehľad produktov:

Active ingredient group (AIG) number: 0152598004; AHFS:

Stav Autorizácia:

APPROVED

Dátum Autorizácia:

2018-12-07

Súhrn charakteristických

_Page 1 of 21 _
PRODUCT MONOGRAPH
THALLOUS CHLORIDE TL 201 INJECTION
Thallium Tl 201
Solution for intravenous use containing per mL, 37 megabecquerels (1
millicurie)
Thallous Chloride Tl 201 at calibration time.
Radiodiagnostic Agent
Curium Canada Inc.
2572 boul. Daniel-Johnson, Suite 245-249
Laval, QC, H7T-2R3
CANADA
Date of Revision: April 26
th
, 2019
CONTROL NUMBER: 225111
_Page 2 of 21 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
SUMMARY PRODUCT INFORMATION
.......................................................................
3
DESCRIPTION...................................................................................................................
3
INDICATIONS AND CLINICAL USE
.............................................................................
5
CONTRAINDICATIONS
..................................................................................................
6
WARNINGS AND PRECAUTIONS
.................................................................................
6
ADVERSE REACTIONS
...................................................................................................
9
DRUG INTERACTIONS
...................................................................................................
9
DOSAGE AND ADMINISTRATION
.............................................................................
10
RADIATION DOSIMETRY
............................................................................................
12
OVERDOSAGE
...............................................................................................................
13
ACTION AND CLINICAL PHARMACOLOGY
........................................................... 13
STORAGE AND STABILITY
.........................................................................................
14
SPECIAL HANDLING INSTRUCTIONS
......................................................................
15
DOSAGE FORMS, COMPOSITION AND PACKAGING
.......................